NFE2L2 and ovarian carcinoma: Some can be used as potential therapeutic targets; for example, NFE2L2 can be used as a therapeutic target for glioblastoma [49], and upregulation of miR-383-5p can suppress proliferation and enhance chemosensitivity in ovarian cancer cells [50].